Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment

NCT04302402 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

132

Enrollment

OTHER_GOV

Sponsor class

Conditions

Dyspepsia

Interventions

DRUG: Rifaximin
DRUG: Placebo

Sponsor

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Collaborators

[object Object]